Loading…

Antiviral Action of Diphenyl Diselenide on Herpes Simplex Virus 2 Infection in Female BALB/c Mice

ABSTRACT Diphenyl diselenide, (PhSe)2, is an organoselenium compound with pharmacological actions mostly related to antioxidant and anti‐inflammatory properties. The study investigated its antiviral and virucidal actions against herpes simplex virus 2 (HSV‐2) infection in vitro and in a vaginal infe...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular biochemistry 2016-07, Vol.117 (7), p.1638-1648
Main Authors: Sartori, Gláubia, Jardim, Natália Silva, Marcondes Sari, Marcel Henrique, Dobrachinski, Fernando, Pesarico, Ana Paula, Rodrigues Jr, Luiz Carlos, Cargnelutti, Juliana, Flores, Eduardo F., Prigol, Marina, Nogueira, Cristina W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3
cites cdi_FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3
container_end_page 1648
container_issue 7
container_start_page 1638
container_title Journal of cellular biochemistry
container_volume 117
creator Sartori, Gláubia
Jardim, Natália Silva
Marcondes Sari, Marcel Henrique
Dobrachinski, Fernando
Pesarico, Ana Paula
Rodrigues Jr, Luiz Carlos
Cargnelutti, Juliana
Flores, Eduardo F.
Prigol, Marina
Nogueira, Cristina W.
description ABSTRACT Diphenyl diselenide, (PhSe)2, is an organoselenium compound with pharmacological actions mostly related to antioxidant and anti‐inflammatory properties. The study investigated its antiviral and virucidal actions against herpes simplex virus 2 (HSV‐2) infection in vitro and in a vaginal infection model in mice. The plaque reduction assay indicated that (PhSe)2 showed virucidal and antiviral actions reducing infectivity in 70.8% and 47%, respectively. The antiviral action of (PhSe)2 against HSV‐2 vaginal infection was performed by infecting mice (105 PFU/ml−1) at day 6. The treatment with (PhSe)2 (5 mg/kg/day, intragastric [i.g.]) followed 5 days before and for more 5 days after infection. The extravaginal lesion score was evaluated from days 6 to 10. At day 11, animals were killed, and histological evaluation, determination of viral load, and TNF‐α and IFN‐γ levels were performed in supernatants of homogenized vaginal tissue. The levels of reactive species (RS), protein carbonyl, non‐protein thiols (NPSH), nitrate/nitrite (NOx), and malondialdehyde (MDA), and the activities of myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) were determined. (PhSe)2 reduced the histological damage, extravaginal lesion scores, the viral load of vaginal tissue, and the activity of MPO, but increased the levels of TNF‐α, IFN‐γ. (PhSe)2 attenuated the increase of RS, MDA, NOx levels and the activity of GR caused by infection. (PhSe)2 also attenuated the reduction of NPSH content and the inhibition of CAT, SOD, and GPx activities. The antiviral action of (PhSe)2 against HSV‐2 infection was related to its immunomodulatory, antioxidant, and anti‐inflammatory properties. J. Cell. Biochem. 117: 1638–1648, 2016. © 2015 Wiley Periodicals, Inc.
doi_str_mv 10.1002/jcb.25457
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794503989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4044228521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3</originalsourceid><addsrcrecordid>eNp1kEtvEzEURi0EoqGw4A8gS2xgMY0fM_Z4mQTSFqWw4NGl5fFcCwfPo3YGmn-PYdoukFjdK93zfbo6CL2k5IwSwpZ725yxqqzkI7SgRMmiFGX5GC2I5KRgnLIT9CylPSFEKc6eohMmBFdSigUyq_7gf_poAl7Zgx96PDj8zo_foT-GvCQI0PsWcL5cQBwh4c--GwPc4m8-TgkzfNk7mKO-x1voTAC8Xu3WS4uvvIXn6IkzIcGLu3mKvm7ff9lcFLtP55eb1a6wlSCyaBwoUKLML0sqKmVbY4gsHW2aRtSKNpRSx1oilaicpbVpQDpKaAkVdy0z_BS9mXvHONxMkA6688lCCKaHYUqaSlVWhKtaZfT1P-h-mGKfv8tULURNiSCZejtTNg4pRXB6jL4z8agp0X-86-xd__We2Vd3jVPTQftA3ovOwHIGfvkAx_836Q-b9X1lMSd8OsDtQ8LEH1pILit9_fFcy2xgu7m61pT_BudHmKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786681060</pqid></control><display><type>article</type><title>Antiviral Action of Diphenyl Diselenide on Herpes Simplex Virus 2 Infection in Female BALB/c Mice</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Sartori, Gláubia ; Jardim, Natália Silva ; Marcondes Sari, Marcel Henrique ; Dobrachinski, Fernando ; Pesarico, Ana Paula ; Rodrigues Jr, Luiz Carlos ; Cargnelutti, Juliana ; Flores, Eduardo F. ; Prigol, Marina ; Nogueira, Cristina W.</creator><creatorcontrib>Sartori, Gláubia ; Jardim, Natália Silva ; Marcondes Sari, Marcel Henrique ; Dobrachinski, Fernando ; Pesarico, Ana Paula ; Rodrigues Jr, Luiz Carlos ; Cargnelutti, Juliana ; Flores, Eduardo F. ; Prigol, Marina ; Nogueira, Cristina W.</creatorcontrib><description>ABSTRACT Diphenyl diselenide, (PhSe)2, is an organoselenium compound with pharmacological actions mostly related to antioxidant and anti‐inflammatory properties. The study investigated its antiviral and virucidal actions against herpes simplex virus 2 (HSV‐2) infection in vitro and in a vaginal infection model in mice. The plaque reduction assay indicated that (PhSe)2 showed virucidal and antiviral actions reducing infectivity in 70.8% and 47%, respectively. The antiviral action of (PhSe)2 against HSV‐2 vaginal infection was performed by infecting mice (105 PFU/ml−1) at day 6. The treatment with (PhSe)2 (5 mg/kg/day, intragastric [i.g.]) followed 5 days before and for more 5 days after infection. The extravaginal lesion score was evaluated from days 6 to 10. At day 11, animals were killed, and histological evaluation, determination of viral load, and TNF‐α and IFN‐γ levels were performed in supernatants of homogenized vaginal tissue. The levels of reactive species (RS), protein carbonyl, non‐protein thiols (NPSH), nitrate/nitrite (NOx), and malondialdehyde (MDA), and the activities of myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) were determined. (PhSe)2 reduced the histological damage, extravaginal lesion scores, the viral load of vaginal tissue, and the activity of MPO, but increased the levels of TNF‐α, IFN‐γ. (PhSe)2 attenuated the increase of RS, MDA, NOx levels and the activity of GR caused by infection. (PhSe)2 also attenuated the reduction of NPSH content and the inhibition of CAT, SOD, and GPx activities. The antiviral action of (PhSe)2 against HSV‐2 infection was related to its immunomodulatory, antioxidant, and anti‐inflammatory properties. J. Cell. Biochem. 117: 1638–1648, 2016. © 2015 Wiley Periodicals, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.25457</identifier><identifier>PMID: 26639776</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Animals ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Antioxidants - pharmacology ; Antiviral Agents - pharmacology ; Benzene Derivatives - pharmacology ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Female ; Herpes Genitalis - blood ; Herpes Genitalis - drug therapy ; Herpes simplex virus 2 ; Herpesvirus 2, Human ; HSV-2 ; IMMUNE SYSTEM ; Immunologic Factors - pharmacology ; INFLAMMATION ; Mice ; Organoselenium Compounds - pharmacology ; OXIDATIVE STRESS ; SELENIUM</subject><ispartof>Journal of cellular biochemistry, 2016-07, Vol.117 (7), p.1638-1648</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><rights>2016 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3</citedby><cites>FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26639776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sartori, Gláubia</creatorcontrib><creatorcontrib>Jardim, Natália Silva</creatorcontrib><creatorcontrib>Marcondes Sari, Marcel Henrique</creatorcontrib><creatorcontrib>Dobrachinski, Fernando</creatorcontrib><creatorcontrib>Pesarico, Ana Paula</creatorcontrib><creatorcontrib>Rodrigues Jr, Luiz Carlos</creatorcontrib><creatorcontrib>Cargnelutti, Juliana</creatorcontrib><creatorcontrib>Flores, Eduardo F.</creatorcontrib><creatorcontrib>Prigol, Marina</creatorcontrib><creatorcontrib>Nogueira, Cristina W.</creatorcontrib><title>Antiviral Action of Diphenyl Diselenide on Herpes Simplex Virus 2 Infection in Female BALB/c Mice</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>ABSTRACT Diphenyl diselenide, (PhSe)2, is an organoselenium compound with pharmacological actions mostly related to antioxidant and anti‐inflammatory properties. The study investigated its antiviral and virucidal actions against herpes simplex virus 2 (HSV‐2) infection in vitro and in a vaginal infection model in mice. The plaque reduction assay indicated that (PhSe)2 showed virucidal and antiviral actions reducing infectivity in 70.8% and 47%, respectively. The antiviral action of (PhSe)2 against HSV‐2 vaginal infection was performed by infecting mice (105 PFU/ml−1) at day 6. The treatment with (PhSe)2 (5 mg/kg/day, intragastric [i.g.]) followed 5 days before and for more 5 days after infection. The extravaginal lesion score was evaluated from days 6 to 10. At day 11, animals were killed, and histological evaluation, determination of viral load, and TNF‐α and IFN‐γ levels were performed in supernatants of homogenized vaginal tissue. The levels of reactive species (RS), protein carbonyl, non‐protein thiols (NPSH), nitrate/nitrite (NOx), and malondialdehyde (MDA), and the activities of myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) were determined. (PhSe)2 reduced the histological damage, extravaginal lesion scores, the viral load of vaginal tissue, and the activity of MPO, but increased the levels of TNF‐α, IFN‐γ. (PhSe)2 attenuated the increase of RS, MDA, NOx levels and the activity of GR caused by infection. (PhSe)2 also attenuated the reduction of NPSH content and the inhibition of CAT, SOD, and GPx activities. The antiviral action of (PhSe)2 against HSV‐2 infection was related to its immunomodulatory, antioxidant, and anti‐inflammatory properties. J. Cell. Biochem. 117: 1638–1648, 2016. © 2015 Wiley Periodicals, Inc.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Antioxidants - pharmacology</subject><subject>Antiviral Agents - pharmacology</subject><subject>Benzene Derivatives - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Evaluation, Preclinical</subject><subject>Female</subject><subject>Herpes Genitalis - blood</subject><subject>Herpes Genitalis - drug therapy</subject><subject>Herpes simplex virus 2</subject><subject>Herpesvirus 2, Human</subject><subject>HSV-2</subject><subject>IMMUNE SYSTEM</subject><subject>Immunologic Factors - pharmacology</subject><subject>INFLAMMATION</subject><subject>Mice</subject><subject>Organoselenium Compounds - pharmacology</subject><subject>OXIDATIVE STRESS</subject><subject>SELENIUM</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kEtvEzEURi0EoqGw4A8gS2xgMY0fM_Z4mQTSFqWw4NGl5fFcCwfPo3YGmn-PYdoukFjdK93zfbo6CL2k5IwSwpZ725yxqqzkI7SgRMmiFGX5GC2I5KRgnLIT9CylPSFEKc6eohMmBFdSigUyq_7gf_poAl7Zgx96PDj8zo_foT-GvCQI0PsWcL5cQBwh4c--GwPc4m8-TgkzfNk7mKO-x1voTAC8Xu3WS4uvvIXn6IkzIcGLu3mKvm7ff9lcFLtP55eb1a6wlSCyaBwoUKLML0sqKmVbY4gsHW2aRtSKNpRSx1oilaicpbVpQDpKaAkVdy0z_BS9mXvHONxMkA6688lCCKaHYUqaSlVWhKtaZfT1P-h-mGKfv8tULURNiSCZejtTNg4pRXB6jL4z8agp0X-86-xd__We2Vd3jVPTQftA3ovOwHIGfvkAx_836Q-b9X1lMSd8OsDtQ8LEH1pILit9_fFcy2xgu7m61pT_BudHmKw</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Sartori, Gláubia</creator><creator>Jardim, Natália Silva</creator><creator>Marcondes Sari, Marcel Henrique</creator><creator>Dobrachinski, Fernando</creator><creator>Pesarico, Ana Paula</creator><creator>Rodrigues Jr, Luiz Carlos</creator><creator>Cargnelutti, Juliana</creator><creator>Flores, Eduardo F.</creator><creator>Prigol, Marina</creator><creator>Nogueira, Cristina W.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>201607</creationdate><title>Antiviral Action of Diphenyl Diselenide on Herpes Simplex Virus 2 Infection in Female BALB/c Mice</title><author>Sartori, Gláubia ; Jardim, Natália Silva ; Marcondes Sari, Marcel Henrique ; Dobrachinski, Fernando ; Pesarico, Ana Paula ; Rodrigues Jr, Luiz Carlos ; Cargnelutti, Juliana ; Flores, Eduardo F. ; Prigol, Marina ; Nogueira, Cristina W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Antioxidants - pharmacology</topic><topic>Antiviral Agents - pharmacology</topic><topic>Benzene Derivatives - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Evaluation, Preclinical</topic><topic>Female</topic><topic>Herpes Genitalis - blood</topic><topic>Herpes Genitalis - drug therapy</topic><topic>Herpes simplex virus 2</topic><topic>Herpesvirus 2, Human</topic><topic>HSV-2</topic><topic>IMMUNE SYSTEM</topic><topic>Immunologic Factors - pharmacology</topic><topic>INFLAMMATION</topic><topic>Mice</topic><topic>Organoselenium Compounds - pharmacology</topic><topic>OXIDATIVE STRESS</topic><topic>SELENIUM</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sartori, Gláubia</creatorcontrib><creatorcontrib>Jardim, Natália Silva</creatorcontrib><creatorcontrib>Marcondes Sari, Marcel Henrique</creatorcontrib><creatorcontrib>Dobrachinski, Fernando</creatorcontrib><creatorcontrib>Pesarico, Ana Paula</creatorcontrib><creatorcontrib>Rodrigues Jr, Luiz Carlos</creatorcontrib><creatorcontrib>Cargnelutti, Juliana</creatorcontrib><creatorcontrib>Flores, Eduardo F.</creatorcontrib><creatorcontrib>Prigol, Marina</creatorcontrib><creatorcontrib>Nogueira, Cristina W.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sartori, Gláubia</au><au>Jardim, Natália Silva</au><au>Marcondes Sari, Marcel Henrique</au><au>Dobrachinski, Fernando</au><au>Pesarico, Ana Paula</au><au>Rodrigues Jr, Luiz Carlos</au><au>Cargnelutti, Juliana</au><au>Flores, Eduardo F.</au><au>Prigol, Marina</au><au>Nogueira, Cristina W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiviral Action of Diphenyl Diselenide on Herpes Simplex Virus 2 Infection in Female BALB/c Mice</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2016-07</date><risdate>2016</risdate><volume>117</volume><issue>7</issue><spage>1638</spage><epage>1648</epage><pages>1638-1648</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>ABSTRACT Diphenyl diselenide, (PhSe)2, is an organoselenium compound with pharmacological actions mostly related to antioxidant and anti‐inflammatory properties. The study investigated its antiviral and virucidal actions against herpes simplex virus 2 (HSV‐2) infection in vitro and in a vaginal infection model in mice. The plaque reduction assay indicated that (PhSe)2 showed virucidal and antiviral actions reducing infectivity in 70.8% and 47%, respectively. The antiviral action of (PhSe)2 against HSV‐2 vaginal infection was performed by infecting mice (105 PFU/ml−1) at day 6. The treatment with (PhSe)2 (5 mg/kg/day, intragastric [i.g.]) followed 5 days before and for more 5 days after infection. The extravaginal lesion score was evaluated from days 6 to 10. At day 11, animals were killed, and histological evaluation, determination of viral load, and TNF‐α and IFN‐γ levels were performed in supernatants of homogenized vaginal tissue. The levels of reactive species (RS), protein carbonyl, non‐protein thiols (NPSH), nitrate/nitrite (NOx), and malondialdehyde (MDA), and the activities of myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) were determined. (PhSe)2 reduced the histological damage, extravaginal lesion scores, the viral load of vaginal tissue, and the activity of MPO, but increased the levels of TNF‐α, IFN‐γ. (PhSe)2 attenuated the increase of RS, MDA, NOx levels and the activity of GR caused by infection. (PhSe)2 also attenuated the reduction of NPSH content and the inhibition of CAT, SOD, and GPx activities. The antiviral action of (PhSe)2 against HSV‐2 infection was related to its immunomodulatory, antioxidant, and anti‐inflammatory properties. J. Cell. Biochem. 117: 1638–1648, 2016. © 2015 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26639776</pmid><doi>10.1002/jcb.25457</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2016-07, Vol.117 (7), p.1638-1648
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_1794503989
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
Antioxidants - pharmacology
Antiviral Agents - pharmacology
Benzene Derivatives - pharmacology
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Female
Herpes Genitalis - blood
Herpes Genitalis - drug therapy
Herpes simplex virus 2
Herpesvirus 2, Human
HSV-2
IMMUNE SYSTEM
Immunologic Factors - pharmacology
INFLAMMATION
Mice
Organoselenium Compounds - pharmacology
OXIDATIVE STRESS
SELENIUM
title Antiviral Action of Diphenyl Diselenide on Herpes Simplex Virus 2 Infection in Female BALB/c Mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A39%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiviral%20Action%20of%20Diphenyl%20Diselenide%20on%20Herpes%20Simplex%20Virus%202%20Infection%20in%20Female%20BALB/c%20Mice&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Sartori,%20Gl%C3%A1ubia&rft.date=2016-07&rft.volume=117&rft.issue=7&rft.spage=1638&rft.epage=1648&rft.pages=1638-1648&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.25457&rft_dat=%3Cproquest_cross%3E4044228521%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5607-bfe9e96473071659cdaa074f1bbb6891b111f2d07965fc18abe7f1014e53fd2a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1786681060&rft_id=info:pmid/26639776&rfr_iscdi=true